PHILLIP FROST - 04 Sep 2025 Form 4 Insider Report for Fluent, Inc. (FLNT)

Role
10%+ Owner
Signature
/s/ Dr. Phillip Frost, M.D., Trustee
Issuer symbol
FLNT
Transactions as of
04 Sep 2025
Net transactions value
-$999,715
Form type
4
Filing time
08 Sep 2025, 17:03:53 UTC
Previous filing
21 Aug 2025
Next filing
15 Sep 2025
SEC
View on sec.gov

Reporting Owners (2)

Name Relationship Address Signature Signature date CIK
FROST PHILLIP MD ET AL 10%+ Owner 4400 BISCAYNE BLVD, MIAMI /s/ Dr. Phillip Frost, M.D., Trustee 08 Sep 2025 0000898860
Frost Gamma Investments Trust 10%+ Owner 4400 BISCAYNE BLVD, MIAMI /s/ Dr. Phillip Frost, M.D., Individually 08 Sep 2025 0001380896
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLNT Common Stock Other $286 +571,429 +8.5% $0.000500 7,294,403 04 Sep 2025 Held by Frost Gamma Investments Trust F1
holding FLNT Common Stock 8,334 04 Sep 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLNT Pre-Funded Warrants Disposed to Issuer $1,000,001 -571,429 -100% $1.75 0 04 Sep 2025 Common Stock 571,429 $0.000500 Held by Frost Gamma Investments Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 The Pre-Funded Warrants expire when exercised in full.
F3 The Pre-Funded Warrants were immediately exercisable when issued and were exercised on September 4, 2025.